Bill Text: US HB383 | 2023-2024 | 118th Congress | Introduced
Bill Title: To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
Spectrum: Partisan Bill (Republican 27-0)
Status: (Introduced) 2023-01-27 - Referred to the Subcommittee on Health. [HB383 Detail]
Download: US_Congress-2023-HB383-Introduced.pdf